Physician
Dermatology
Dr. Lucy M. Schmidt, MD
|
|
Give Review
Lucy M. Schmidt, MD works in the field of Dermatology. She attended Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. She received awards:"Fellow (FAAD)". Lucy Schmidt is a published MD. She has 27 papers published. The most current publication "Characterization of a TPA-response element in the 5'-flanking region of the androgen receptor gene." She accepts Medicare payments and is listed with Medicare.gov.
Publications
- The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer Cells.
- Androgen receptor: past, present and future.
- Organization and expression of endogenous virus-like (VL30) DNA sequences in nontransformed and chemically transformed mouse embryo Cells in culture.
- Plasticity of vascular smooth muscle alpha-actin gene transcription. Characterization of multiple, single-, and double-strand specific DNA-binding proteins in myoblast...
- Activation of a muscle-specific actin gene promoter in serum-stimulated fibroblasts.
- Evidence that the functional beta-actin gene is single copy in most mice and is associated with 5' sequences capable of conferring serum- and cycloheximide-dependent r...
- Negative regulation of serum-responsive enhancer elements.
- Characterization of a TPA-response element in the 5'-flanking region of the androgen receptor gene.
- PTEN induces chemosensitivity in PTEN-mutated prostate cancer Cells by suppression of Bcl-2 expression.
- Role of PI3K signaling in survival and progression of LNCaP prostate cancer Cells to the androgen refractory state.
- Tyrphostin AG825 triggers p38 mitogen-activated protein kinase-dependent apoptosis in androgen-independent prostate cancer Cells C4 and C4-2.
- Identification of a clinically relevant androgen-dependent gene signature in prostate cancer.
- Steroid 5 α-reductase inhibitors targeting BPH and prostate cancer.
- Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial Cells.
- Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression.
- Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenografts.
- Androgen modulation of coregulator expression in prostate cancer Cells.
- Expression and significance of androgen receptor coactivators in urothelial Carcinoma of the bladder.
- Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.
- Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer Cells.
- Inhibition of fatty acid synthase activity in prostate cancer Cells by dutasteride.
- Prostate cancer Cells use genetic and epigenetic mechanisms for progression to androgen independence.
- p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer Cells treated chronically with interleukin-6.
- Gene expression in prostate cancer Cells treated with the dual 5 alpha-reductase inhibitor dutasteride.
- p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6.
- Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer Cells.
Schools
Johns Hopkins University School of Medicine
Johns Hopkins University
Procedures Preformed
- Acne Surgery
- Destruction of Benign Skin Lesion
- Destruction of Penile Lesion
- Excision of Benign Skin Lesion
- View All
Conditions Treated
- Acanthosis Nigricans
- Acne
- Actinic Keratosis
- Athlete's Foot
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- Fellow (FAAD)
Education
-
Johns Hopkins University -
Johns Hopkins University School of Medicine
Hospital
-
Mills-Peninsula Health Services -
Stanford Health Care
Drug Facts
| NPI NUMBER | 1194789628 | |
| NPPES Provider LastName | SCHMIDT | |
| NPPES Provider FirstName | LUCY | |
| NPPES Provider ZIPCode | 944012889 | |
| NPPES Provider State | CA | |
| Specialty Description | Dermatology | |
| Total Claim Count | 674.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1194789628 |
| Last Name Of The Provider | SCHMIDT |
| First Name Of The Provider | LUCY |
| View All |
Similar Doctors
|
|
Dr. Werner W. Ju, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter K. Webb, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Susan T. Butler, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bruce L. Maltz, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Carie T. Chui, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Weinberg, MD |
|
Dr. Susan D. Wolf, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley A. Young, MD
This Doctor is OpenDoctor Recommended.
|